Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000075.xml
Download PDF
Semin Respir Crit Care Med 2000; Volume 21(Number 05): 451-462
DOI: 10.1055/s-2000-9407
DOI: 10.1055/s-2000-9407
Evaluation and Management of the Complications of Lung Cancer Treatment
Further Information
Publication History
Publication Date:
31 December 2000 (online)
ABSTRACT
The principal treatment-related complications encountered in the management of lung cancer are presented with particular reference to surgery, radiotherapy, and chemotherapy. The clinical features, risk factors, and management of the complications are discussed.
KEYWORD
Lung cancer - surgery - radiotherapy - chemotherapy - complications
REFERENCES
- 1 McIntosh H C, Spitz S. A study of radiation pneumonitis. AJR . 1939; 41 605-615
- 2 Van der Kogel A J, Ang K K. Complications related to radiotherapy. In: Peckham M, Pinedo H, Veronesi U, eds. Oxford Textbook of Oncology
Oxford: Oxford University Press, 1995: 2295-306
MissingFormLabel
- 3 Pearson F G. Current status of surgical resection for lung cancer. Chest . 1994; 106 337-339S
- 4 Silverberg E, Boring C C, Squires T S. Cancer Statistics. CA Cancer J Clin . 1990; 40 9-26
- 5 Deslauriers J, Ginsberg R J, Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest . 1994; 106 329-330S
- 6 Ginsberg R J, Hill L D, Eagan R T. Modern thirty-day operative mortality for surgical resection in lung cancer. J Thorac Cardiovasc Surg . 1983; 86 654-658
- 7 Markos J, Mullan B P, Hillman D R. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis . 1989; 139 902-910
- 8 Nagasaki F, Flehinger B J, Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest . 1982; 82 25-29
- 9 Wyser C, Stulz P, Soler M. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med . 1999; 159 1450-1456
- 10 Van der Kogel A J. Radiation response and tolerance of normal tissues. In: Steel GG, ed. Basic Clinical Radiobiology. London: Arnold; . 1997; 30-39
- 11 Movsas B, Raffin T A, Epstein A H. Pulmonary radiation injury. Chest . 1997; 111 1061-1076
- 12 Davies S D, Yankelevitz D F, Henschke C I. Radiation effects on the lung: Clinical features, Pathology, and Imaging Findings. AJR . 1992; 159 1157-1164
- 13 Van Houtte P. Mornex P. Radiotherapy of non-small-cell and small-cell and SCLC. Lung cancer. In: Spiro SG, ed. Carcinoma of the Lung. European Respiratory Monograph, vol. 1 Oct.
1995: 241-268
MissingFormLabel
- 14 Fried J R, Goldberg H. Post-irradiation changes in the lung and thorax. Am J Roentgenol . 1940; 43 877-895
- 15 Ross W M. Radiotherapeutic and radiological aspects of radiation fibrosis of the lungs. Thorax . 1956; 11 241-246
- 16 Libshitz H I, Southard M E. Complications of radiation therapy: The thorax. Semin Roentgenol . 1974; 9 41-49
- 17 Roswit B, White D C. Severe radiation injuries of the lung. AJR . 1977; 129 127-136
- 18 Bate D, Guttemann R J. Changes in the lung and pleura following 2-million volt therapy for carcinoma of the breast. Radiology . 1957; 69 372-382
- 19 Bachman A L, Macken K. Pleural effusions following supervoltage radiation for breast carcinoma. Radiology . 1959; 72 699-709
- 20 Libshitz H I, Southard M E. Complications of radiation therapy: The thorax. Semin Roentgenol . 1974; 9 41-49
- 21 Pagani J J, Libshitz H I. CT manifestations of radiation-induced change in chest tissue. J Comput Assist Tomogr . 1982; 6 243-248
- 22 Libshitz H I, Shuman L S. Radiation-induced pulmonary change: CT findings. J Comput Assist Tomogr . 1984; 8 15-19
- 23 Mah K, Poon P Y, Van Dyk J. Assessment of acute radiation-induced pulmonary changes using computed tomography. J Comput Assist Tomogr . 1986; 10 736-743
- 24 Bourgouin P, Cousineau G, Lemire P. Differentiation of radiation-induced fibrosis from recurrent pulmonary neoplasm by CT. Can Assoc Radiol J . 1987; 38 23-26
- 25 Ikezoe J, Takashima S, Morimoto S. CT appearance of acute radiation-induced injury in the lung. AJR . 1988; 150 765-770
- 26 Bell J, McGivern D, Bullimore J. Diagnostic imaging of post-irradiation changes in the chest. Clin Radiol . 1988; 39 109-119
- 27 Frija J, Ferme C, Baud L. Radiation-induced lung injuries: A survey of computed tomography and pulmonary function tests in 18 cases of Hodgkin's disease. Eur J Radiol . 1988; 8 18-23
- 28 Ikezoe J, Morimoto S, Takashima S. Acute radiation-induced pulmonary injury: Computed tomography evaluation. Semin Ultrasound CT MR . 1990; 11 409-416
- 29 Glazer H S, Lee J KT, Levitt R G. Radiation fibrosis: Differentiation from recurrent tumor by MR imaging. Radiology . 1985; 156 721-726
- 30 Kataoka M, Kawamura M, Itho H. Ga-67 citrate scintigraphy for the early detection of radiation pneumonitis. Clin Nucl Med . 1992; 17 27-31
- 31 Evans R F, Sagerman R H, Ringrose T L. Pulmonary function following mantle-field irradiation for Hodgkin's disease. Radiology . 1974; 111 729-731
- 32 Brady L W, German P A, Cander L. The effects of radiation therapy on pulmonary function in carcinoma of the lung. Radiology . 1965; 85 130-134
- 33 Watchie J, Coleman C N, Raffin T A. Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys . 1987; 13 517-524
- 34 Lokich J J, Brass H, Eberly F E. The pulmonary effect of mantle irradiation in patients with Hodgkin's disease. Radiology . 1973; 108 397-402
- 35 Host H, Vale J R. Lung function after mantle field irradiation in Hodgkin's disease. Cancer . 1973; 32 328-332
- 36 Wolin E M, Rosenberg S A, Kaplan H S. A randomized comparison of PAVe and MOP (P) as adjuvant therapy for Hodgkin's disease. In: Salmon SE, Jones SE, eds. Adjuvant Therapy of Cancer
New York: Grune & Stratton, 1979: 119-127
MissingFormLabel
- 37 Rubin O, Casarett G W. Clinical Radiation Pathology.
Philadelphia: WB Saunders, 1968: 423-470
MissingFormLabel
- 38 Gross N J, Narine K R, Wade R. Protective effect of corticosteroids on radiation pneumonitis in mice. Radiat Res . 1988; 113 112-119
- 39 Gross N J. Pulmonary effects of radiation therapy. Ann Intern Med . 1977; 86 81-92
- 40 Castellino R A, Glastein E, Turbow M M. Latent radiation injury of lungs or heart activated by steroid withdrawal. Ann Intern Med . 1974; 80 593-599
- 41 Rotstein S, Blomgren H, Baral E. Incidence of infectious symptoms after radiation therapy for breast cancer: Long-term effects. Acta Oncol . 1987; 26 197-201
- 42 Gross N j, Holloway N O, Narine K R. Effects of nonsteroidal anti-inflammatory agents on experimental radiation pneumonitis. Radiat Res . 1991; 127 317-324
- 43 Coggle J E, Lambert B E, Moores S R. Radiation effects in the lung. Environ Health Perspect . 1986; 70 261-291
- 44 Gross N J. Pulmonary effects of radiation therapy. Ann Intern Med . 1977; 86 81-92
- 45 Roswitt B, White D C. Severe radiation injuries of the lung. AJR . 1977; 129 127-136
- 46 Bennett D E, Million R R, Ackerman L V. Bilateral radiation pneumonitis, a complication of the radiotherapy of bronchogenic carcinoma. Cancer . 1969; 23 1001-1018
- 47 Stone D J, Schwartz M J, Green R A. Fatal pulmonary insufficiency due to radiation effect upon the lung. Am J Med . 1956; 21 211-226
- 48 Whitfield G W, Bond W H, Arnott W M. Radiation reactions in the lung. Q J Med . 1956; 97 69-86
- 49 Kaufman J, Komorowski R. Bronchiolitis obliterans, a new clinical-pathologic complication of irradiation pneumonitis. Chest . 1990; 97 1243-1244
- 50 Crestani B, Kambouchner M, Soler P. Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma. Eur Respir J . 1995; 8 318-321
- 51 Bayle J Y, Nesme P, Bejui-Thivolet F. Migratory organizing pneumonitis ``primed'' by radiation therapy. Eur Respir J . 1995; 8 322-326
- 52 Van Laar J M, Holscher H C, Van Krieken J HJM. Bronchiolitis obliterans organizing pneumonia after adjuvant radiotherapy for breast carcinoma. Respir Med . 1997; 91 241-244
- 53 Crestani B, Valeyre D, Roden S. Bronchiolitis obliterans organising pneumonia syndrome primed by radiation therapy to the breast. Am J Respir Crit Care Med . 1998; 158 1929-1935
- 54 Martin C, Romero S, Sanchez-Paya J. Bilateral lymphocytic alveolitis: A common reaction after unilateral thoracic irradiation. Eur Respir J . 1999; 13 727-732
- 55 Prakash U BS. Radiation-induced injury in the ``nonirradiated'' lung. Eur Respir J . 1999; 13 715-717
- 56 Stewart J R, Fajardo L F. Radiation-induced heart disease: An update. Prog Cardiovasc Dis . 1984; 27 173-194
- 57 Schultz-Hector S. Heart. In: Scherer E, Streffer C, Trott KR, eds. Radiopathology of Organs and Tissues
Berlin: Springer-Verlag, 1991: 347-368
MissingFormLabel
- 58 Brosius F C, Waller B F, Roberts W L. Analysis of 16 young (aged 15-33 years) necropsy patients who received over 3500 rads to the heart. Am J Med . 1981; 70 519-530
- 59 PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet . 1998; 352 257-263
- 60 Dautzenberg B, Arriagada R, Chammard A B. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer . 1999; 86 265-273
- 61 Van der Kogel AJ. The nervous system: Radiobiology and experimental pathology. In: SchererE, Streffer C, Trott, eds. Radiopathology of Organs and Tissues
Heidelberg: Springer-Verlag, 1991: 191-212
MissingFormLabel
- 62 Macbeth F R, Wheldon, T E, Girling D J. Radiation myelopathy: Estimates of risk in 1048 patients in three randomised trials of palliative radiotherapy for non-small cell lung cancer. Clin Oncol . 1996; 8 176-181
- 63 Glantz M J, Choy H, Yee L. Prophylactic cranial irradiation in small cell lung cancer: Rationale, results, and recommendations. Semin Oncol . 1997; 24 477-483
- 64 Auperin A, Arriagada R, Pignon J P. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med . 1999; 341 476-484
- 65 Feld R, Clamon G H, Blunn R. Short course prophylactic cranial irradiation for small cell lung cancer. Am J Clin Oncol . 1985; 8 371-376
- 66 Posner J B. Neurologic Complications of Cancer.
Philadelphia, PA: FA Davies, 1995: 96-100
MissingFormLabel
- 67 Perez C A, Einhorn L, Oldham R K. Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: A preliminary report. J Clin Oncol . 1984; 2 1200-1208
- 68 Catane R, Schwade J G, Yarr I. Follow-up and neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys . 1981; 7 105-109
- 69 Johnson B E, Patronas N, Hayes W. Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung carcinoma: Further follow-up of 6- to 13-year survivors. J Clin Oncol . 1990; 8 48-56
- 70 Lee J S, Umsawasdi T, Lee Y Y. Neurotoxicity in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys . 1986; 12 313-321
- 71 Lishner M, Feld R, Payne D G. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: The Toronto experience. J Clin Oncol . 1990; 8 215-221
- 72 Frytak S, Shaw J N, O'Neill B P. Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol . 1989; 12 27-33
- 73 Ahles T A, Silberfarb P M, Herndon II J. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukaemia Group B. J Clin Oncol . 1998; 16 1954-1960
- 74 Arriagada R, Le Chevalier T, Borie F. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst . 1995; 87 183-190
- 75 Gregor A, Cull A, Stephens R J. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial. Eur J Cancer . 1997; 33 1752-1758
- 76 Johnson B E, Cortazar P, Chute J P. Second lung cancers in patients successfully treated for lung cancer. Semin Oncol . 1997; 24 1-9
- 77 Van Bodegom P Cv, Wagenaar S S, Corrin B. Second primary lung cancer: Importance of long term follow up. Thorax . 1989; 44 788-793
- 78 Sugimura H, Watanabe S, Tsugane S. Case-control study on histologically determined multiple primary lung cancer. J Natl Cancer Inst . 1987; 79 435-441
- 79 Mathisen D J, Jensik R J, Faber L P. Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg . 1984; 82 502-510
- 80 Wu S C, Lin Z Q, Xu C W. Multiple primary lung cancers. Chest . 1987; 92 892-896
- 81 Deschamps C, Pairolero P C, Trastek V F. Multiple primary lung cancers: Results of surgical treatment. Ann Thorac Cardiovasc Surg . 1990; 99 769-778
- 82 Abrahamsen J F, Andersen A, Hannisdal E. Second malignancies after treatment of Hodgkin's Disease: The influence of treatment, follow-up time, and age. J Clin Oncol . 1993; 11 255-261
- 83 Swerdlow A J, Douglas A J, Vaughan Hudson G. Risk of second primary cancers after Hodgkin's Disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. Br Med J . 1992; 304 1137-1143
- 84 Tucker M A, Coleman C N, Cox R S. Risk of second cancers after treatment for Hodgkin's Disease. N Engl J Med . 1988; 318 76-81
- 85 Van Leeuwen F E, Klikman W J, Hagenbeek A. Second cancer risk following Hodgkin's Disease: A 20-year follow-up study. J Clin Oncol . 1994; 12 312-325
- 86 Kirova Y M, FeuilhadeF, Calitchi E. Radiation-induced sarcoma after breast cancer. Apropos of 8 cases and review of the literature. Cancer-Radiother . 1998; 2 381-386
- 87 Ihde D c. Drug therapy. Chemotherapy for lung cancer. N Engl J Med . 1992; 12 1434-1441
- 88 Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J . 1995; 11 899-909
- 89 Smit E F, Postmus P E. Chemotherapy of small cell lung cancer. In: Carney DN, ed. Lung cancer
London: Edward Arnold, 1995: 156-172
MissingFormLabel
- 90 Rosell R, Gomez-Codina J, Camps C. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med . 1994; 330 153-158
- 91 Roth J A, Fossell F, Komaki R. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst . 1994; 86 673-680
- 92 Weiss R B, Vogelzang N J. Miscellaneous toxicities. In: Devita, VT Jnr, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology
Philadelphia: JB Lippincott Company, 1993: 2349-2358
MissingFormLabel
- 93 Steinherz L J, Yahalom J. Cardiac complications of cancer therapy. In: Devita, VT Jnr, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology
Philadelphia: JB Lippincott Company, 1993: 2370-2385
MissingFormLabel
- 94 Talcott J A, Finberg R, Mayer R J. The medical course of cancer patients with fever and neutropenia: Clinical identification of a low-risk subgroup at presentation. Arch Intern Med . 1988; 148 2561-2568
- 95 Talcott J A, Siegel R D, Finberg R. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule. J Clin Oncol . 1992; 10 316-322
- 96 Freifeld A, Marchigiani D, Walsh T. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med . 1999; 341 305-311
- 97 Kern W V, Cometta A, De Bock R. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med . 1999; 341 312-318
- 98 Hirsch F R, Hansen H H, Hansen M. The superiority of combination chemotherapy including etoposide based on in vivo cycle analysis in the treatment of small-cell lung cancer: A randomised trial of 288 consecutive patients. J Clin Oncol . 1987; 5 585-591
- 99 Stephens R J, Girling D J, Machin D. Treatment related deaths in small cell lung cancer trials: Can patients at risk be identified?. Lung Cancer . 1994; 11 259-274
- 100 Morittu L, Earl H M, Souhami R L. Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer . 1989; 59 801-804
- 101 Johnson D H. Small cell lung cancer in the elderly patient. Semin Oncol . 1997; 24 484-491
- 102 Urban T, Lebeau B. Colony-stimulating factor therapy and febrile neutropenia induced by chemotherapy: Need for economical studies. Eur Respir J . 1999; 13 1228-1229
- 103 Crawford J, Ozer H, Stoller R. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med . 1991; 325 164-170
- 104 Trillet-Lehoir V, Green J, Manegold C. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer . 1993; 29 319-324
- 105 Maher D W, Lieschke G J, Green M. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med . 1994; 121 492-501
- 106 Mayordomo J I, Rivera F, Diaz-Puente M. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. J Natl Cancer Inst . 1995; 87 803-808
- 107 Anaissie E J, Vartivarian S, Bodey G P. Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia. Am J Med . 1996; 100 17-23
- 108 Cooper J AD, White D A, Matthay R A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis . 1986; 133 321-340
- 109 Israel-Biet D, Labrune S, Huchon, G J. Drug-induced lung disease: 1990 review. Eur Respir J . 1991; 4 465-478
- 110 Foucher P, Biour M, Blayac J P. Drugs which may injure the respiratory system. Eur Respir J . 1997; 10 265-279
- 111 Hesketh P J, Gandara. A new class of antiemetic agents. J Natl Cancer Inst . 1991; 83 613-620